Access and Evidence
RWE’s new dataset: Social media
Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond
Commercial
Omnichannel: How will pharma get there?
The goal is clear for pharma: true omnichannel engagement. A complete view of digital and in-person touchpoints for each...
Patients and Medical
Advancing health equity for the LGBTQIA+ community
Healthcare systems are failing the LGBTQIA+ community and transgender individuals in particular. Too often they are not getting the care...
Latest
-
-
Multichannel
Scaling CGT through automation
Delivering on the promise of cell and gene therapies requires significant process improvements to cut manufacturing time and costs -
Patients and Medical
Advancing health equity for the LGBTQIA+ community
Marginalised and with a range of unmet health needs, LGBTQIA+ patients are not getting the care they need. Pharma can help. -
Commercial
Omnichannel: How will pharma get there?
The journey from multichannel to omnichannel requires closer data co-ordination, an agile approach, new metrics and nimbler content management -
Patients and Medical
Advocacy in Hemophilia: Building the Future by Design
Creating a visionary paradigm for the future of hemophilia and rare diseases that disrupts current thinking
Most Popular
Brian Eastwood, (Nov 8, 2022)
The journey from multichannel to omnichannel requires closer data co-ordination, an agile approach, new metrics and nimbler content management
Clare Jackson, (Nov 3, 2022)
Creating a visionary paradigm for the future of hemophilia and rare diseases that disrupts current thinking
Katie Delaney, (Nov 9, 2022)
Marginalised and with a range of unmet health needs, LGBTQIA+ patients are not getting the care they need. Pharma can help.
Opinion
Jill Donahue, (Sep 5, 2022)
For Ana Paula Carvalho, President of Western Europe Cluster, Pfizer, her purpose began amidst overcoming challenges.
Jill Donahue, (Feb 13, 2022)
Paying it forward and helping others act on their patient-driven purpose is the goal of this pharma leader
Commercial
-
Omnichannel: How will pharma get there?
The journey from multichannel to omnichannel requires closer data co-ordination, an agile approach, new metrics and nimbler content management -
Becoming agile in experience measurement
The customer experience is pharma’s new competitive battleground – trust is its key metric, and the prizes will go to the nimble -
Paving the payment path for DTx
The digital therapeutics reimbursement process is maturing but complexity and risk remain to be managed -
The field force: Is small beautiful?
As big pharma ponders the right sizing of its post-pandemic field forces, can it learn from smaller, leaner industry peers about doing more with less? -
Cell & Gene Therapy: High stakes and high hopes for healthcare
Now that CGT is proving its worth, the next task for pharma is working out the best ways to commercialise it
Access and Evidence
-
RWE’s new dataset: Social media
Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond -
How automation is changing regulatory affairs
Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing -
An early peek at the FDA’s RWE ‘cookbook’
The FDA is developing guidelines that will help pharma accelerate its adoption of RWE, this is what the industry should know -
The future is bright for RWE in pharma approvals
The FDA and other regulatory bodies are increasingly willing to accept real-world evidence as part of approvals. Pharma is up to the task -
Payers and the ABCs of digital literacy
Convincing payers of the value of digital add-ons and of drug/device combinations requires pharma to demonstrate that patients and other stakeholders understand how to use them
Patients and Medical
-
Digital Health: Letting human nature drive design
End users are increasingly important partners in developing digital health solutions, to the benefit of all -
Advancing health equity for the LGBTQIA+ community
Marginalised and with a range of unmet health needs, LGBTQIA+ patients are not getting the care they need. Pharma can help. -
Advocacy in Hemophilia: Building the Future by Design
Creating a visionary paradigm for the future of hemophilia and rare diseases that disrupts current thinking -
Bringing hope in hemophilia
By collaborating, gathering compelling global data and sharing knowledge hemophilia advocates are driving fairer and broader access to diagnosis and treatment -
Clinical trials: Japan’s next chapter
Post COVID-19, keeping patients at the center of plans for clinical trial design in Japan is vital
Latest Videos
Upcoming Events
View All EventsDecember 2022
-
Advocacy in Hemophilia Series: Crafting a Path that Leaves No One Behind
Dec 14, 2022 - Dec 14, 2022
March 2023
-
Pharma USA 2023
Mar 28, 2023 - Mar 29, 2023
April 2023
-
Pharma Europe 2023
Apr 18, 2023 - Apr 20, 2023